| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 25.6% | Nomura Instinet | → $145 | Upgrades | Neutral → Buy |
| 11/01/2023 | 19.53% | Barclays | $183 → $138 | Maintains | Overweight |
| 10/31/2023 | 81.9% | Benchmark | → $210 | Reiterates | Buy → Buy |
| 10/19/2023 | 60.24% | JP Morgan | $200 → $185 | Maintains | Overweight |
| 09/25/2023 | 45.52% | Bernstein | $160 → $168 | Maintains | Outperform |
| 08/31/2023 | 51.58% | Susquehanna | → $175 | Reiterates | Positive → Positive |
| 08/31/2023 | 81.9% | Benchmark | → $210 | Reiterates | Buy → Buy |
| 08/29/2023 | 64.57% | Loop Capital | $215 → $190 | Maintains | Buy |
| 08/25/2023 | 73.24% | JP Morgan | $190 → $200 | Maintains | Overweight |
| 08/23/2023 | 58.51% | Barclays | $181 → $183 | Maintains | Overweight |
| 08/23/2023 | 47.25% | Mizuho | → $170 | Reiterates | Buy → Buy |
| 08/23/2023 | 81.9% | Benchmark | → $210 | Reiterates | Buy → Buy |
| 08/23/2023 | 92.29% | B of A Securities | $228 → $222 | Maintains | Buy |
| 08/23/2023 | 57.64% | Citigroup | $181 → $182 | Maintains | Buy |
| 07/27/2023 | — | OTR Global | Downgrades | Positive → Mixed | |
| 07/17/2023 | 70.64% | Goldman Sachs | $183 → $197 | Reiterates | Buy → Buy |
| 07/13/2023 | 97.49% | B of A Securities | $234 → $228 | Maintains | Buy |
| 06/20/2023 | 64.57% | Morgan Stanley | $160 → $190 | Upgrades | Equal-Weight → Overweight |
| 05/17/2023 | 47.25% | Mizuho | → $170 | Reiterates | Buy → Buy |
| 05/17/2023 | 81.9% | Benchmark | → $210 | Reiterates | Buy → Buy |
| 05/17/2023 | 45.52% | HSBC | $165 → $168 | Maintains | Buy |
| 05/11/2023 | — | OTR Global | Upgrades | Mixed → Positive | |
| 05/09/2023 | 47.25% | Mizuho | $190 → $170 | Maintains | Buy |
| 05/01/2023 | 38.59% | Bernstein | $109 → $160 | Upgrades | Market Perform → Outperform |
| 04/21/2023 | 55.91% | UBS | $185 → $180 | Maintains | Buy |
| 04/18/2023 | 61.11% | Citigroup | $191 → $186 | Maintains | Buy |
| 04/14/2023 | 42.92% | HSBC | $161 → $165 | Maintains | Buy |
| 04/11/2023 | 64.57% | Mizuho | → $190 | Reiterates | → Buy |
| 03/28/2023 | 86.23% | Loop Capital | $167 → $215 | Maintains | Buy |
| 02/28/2023 | 51.58% | Susquehanna | $150 → $175 | Maintains | Positive |
| 02/23/2023 | 81.9% | Benchmark | $200 → $210 | Maintains | Buy |
| 02/23/2023 | 64.57% | Mizuho | $180 → $190 | Maintains | Buy |
| 02/23/2023 | 65.44% | Citigroup | $176 → $191 | Maintains | Buy |
| 02/23/2023 | 56.78% | Barclays | $139 → $181 | Maintains | Overweight |
| 02/15/2023 | 73.24% | Benchmark | → $200 | Reiterates | → Buy |
| 01/31/2023 | 52.45% | Citigroup | $166 → $176 | Maintains | Buy |
| 01/17/2023 | 81.9% | Jefferies | $217 → $210 | Maintains | Buy |
| 01/17/2023 | 62.84% | Goldman Sachs | $186 → $188 | Maintains | Buy |
| 01/09/2023 | 61.11% | Goldman Sachs | $176 → $186 | Maintains | Buy |
| 11/23/2022 | 52.45% | Goldman Sachs | $184 → $176 | Maintains | Buy |
| 11/23/2022 | 55.91% | Mizuho | $200 → $180 | Maintains | Buy |
| 11/23/2022 | 43.79% | Citigroup | $169 → $166 | Maintains | Buy |
| 11/23/2022 | 51.58% | UBS | $180 → $175 | Maintains | Buy |
| 10/28/2022 | 20.4% | Barclays | $146 → $139 | Maintains | Overweight |
| 10/14/2022 | 46.38% | Citigroup | $204 → $169 | Maintains | Buy |
| 09/12/2022 | 68.9% | Susquehanna | $200 → $195 | Maintains | Positive |
| 09/01/2022 | 73.24% | JP Morgan | $160 → $200 | Upgrades | Neutral → Overweight |
| 08/31/2022 | 76.7% | Citigroup | $223 → $204 | Maintains | Buy |
| 08/23/2022 | 62.84% | Macquarie | → $188 | Initiates Coverage On | → Outperform |
| 05/27/2022 | 133.87% | Benchmark | $330 → $270 | Maintains | Buy |
| 05/27/2022 | 93.16% | Citigroup | $221 → $223 | Maintains | Buy |
| 05/27/2022 | 103.55% | Barclays | $243 → $235 | Maintains | Overweight |
| 05/16/2022 | 8.27% | JP Morgan | $90 → $125 | Upgrades | Underweight → Neutral |
| 05/02/2022 | 146.86% | Mizuho | $300 → $285 | Maintains | Buy |
| 04/08/2022 | 55.91% | HSBC | $195 → $180 | Maintains | Buy |
| 03/03/2022 | 73.24% | Susquehanna | $175 → $200 | Maintains | Positive |
| 03/02/2022 | 97.49% | China Renaissance | $215 → $228 | Maintains | Buy |
| 01/31/2022 | 159.85% | Mizuho | $305 → $300 | Maintains | Buy |
| 11/03/2021 | 110.48% | Barclays | → $243 | Initiates Coverage On | → Overweight |
| 10/27/2021 | — | OTR Global | Downgrades | Positive → Mixed | |
| 10/01/2021 | 31.66% | Arete Research | → $152 | Upgrades | Sell → Neutral |
| 08/18/2021 | 73.24% | Susquehanna | $250 → $200 | Maintains | Positive |
| 08/13/2021 | 177.18% | Oppenheimer | $355 → $320 | Maintains | Outperform |
| 08/13/2021 | 133.87% | Keybanc | $332 → $270 | Maintains | Overweight |
| 05/20/2021 | 155.52% | HSBC | $374 → $295 | Maintains | Buy |
| 05/20/2021 | 116.54% | Susquehanna | $450 → $250 | Maintains | Positive |
| 05/19/2021 | 194.5% | UBS | $370 → $340 | Maintains | Buy |
| 05/19/2021 | 190.17% | CLSA | $350 → $335 | Maintains | Buy |
| 05/19/2021 | 220.49% | Benchmark | $385 → $370 | Maintains | Buy |
| 05/19/2021 | 187.57% | Keybanc | $390 → $332 | Maintains | Overweight |
| 04/15/2021 | 159.85% | China Renaissance | $325 → $300 | Reiterates | → Buy |
| 03/29/2021 | — | Loop Capital | Upgrades | Hold → Buy | |
| 02/23/2021 | 237.81% | Keybanc | $290 → $390 | Maintains | Overweight |
| 02/22/2021 | 246.47% | Barclays | $350 → $400 | Maintains | Overweight |
| 02/18/2021 | 203.16% | Mizuho | $325 → $350 | Maintains | Buy |
| 02/10/2021 | 203.16% | Barclays | $190 → $350 | Maintains | Overweight |
| 02/09/2021 | 181.51% | China Renaissance | $170 → $325 | Upgrades | Hold → Buy |
| 02/08/2021 | 181.51% | Mizuho | $250 → $325 | Maintains | Buy |
| 02/01/2021 | 164.18% | Oppenheimer | $165 → $305 | Maintains | Outperform |
| 01/14/2021 | 151.19% | JP Morgan | $155 → $290 | Maintains | Overweight |
| 01/14/2021 | 151.19% | KeyBanc | $190 → $290 | Maintains | Overweight |
| 11/18/2020 | 64.57% | Keybanc | $182 → $190 | Maintains | Overweight |
| 11/04/2020 | 47.25% | Barclays | → $170 | Upgrades | Equal-Weight → Overweight |
| 10/26/2020 | 57.64% | Keybanc | $177 → $182 | Maintains | Overweight |
| 09/25/2020 | 53.31% | Keybanc | $155 → $177 | Maintains | Overweight |
| 09/08/2020 | 12.6% | Morgan Stanley | $140 → $130 | Downgrades | Overweight → Equal-Weight |
| 08/17/2020 | 51.58% | B of A Securities | $186 → $175 | Maintains | Buy |
| 08/17/2020 | 12.6% | Barclays | $136 → $130 | Maintains | Equal-Weight |
| 08/17/2020 | 34.26% | Keybanc | $145 → $155 | Maintains | Overweight |
| 07/31/2020 | 25.6% | Keybanc | $147 → $145 | Maintains | Overweight |
| 07/28/2020 | 47.25% | Mizuho | $175 → $170 | Maintains | Buy |
| 06/25/2020 | 27.33% | Keybanc | $145 → $147 | Maintains | Overweight |
| 05/20/2020 | 6.54% | Nomura | $120 → $123 | Maintains | Neutral |
| 05/20/2020 | 25.6% | Keybanc | $136 → $145 | Maintains | Overweight |
| 04/23/2020 | 17.8% | Keybanc | $140 → $136 | Maintains | Overweight |
| 04/22/2020 | 14.34% | Barclays | $150 → $132 | Maintains | Equal-Weight |
| 04/17/2020 | 34.26% | Oppenheimer | $165 → $155 | Maintains | Outperform |
| 03/26/2020 | 21.26% | Keybanc | $156 → $140 | Maintains | Overweight |
| 03/11/2020 | 5.67% | Deutsche Bank | → $122 | Reinstates | → Hold |
| 03/03/2020 | 38.59% | Susquehanna | $155 → $160 | Maintains | Positive |
| 03/02/2020 | 65.44% | B of A Securities | $183 → $191 | Reiterates | → Buy |
| 03/02/2020 | 29.93% | JP Morgan | $130 → $150 | Upgrades | Neutral → Overweight |
| 02/24/2020 | 34.26% | Barclays | $150 → $155 | Maintains | Equal-Weight |
| 02/24/2020 | 35.12% | Keybanc | $161 → $156 | Maintains | Overweight |
| 01/21/2020 | 39.45% | Keybanc | $155 → $161 | Maintains | Overweight |
| 01/16/2020 | 42.92% | Oppenheimer | $145 → $165 | Maintains | Outperform |
| 12/04/2019 | 8.27% | Loop Capital | $110 → $125 | Maintains | Hold |
| 11/22/2019 | 16.07% | Macquarie | → $134 | Initiates Coverage On | → Neutral |
| 11/11/2019 | 25.6% | Oppenheimer | → $145 | Upgrades | Perform → Outperform |
| 11/08/2019 | 7.41% | Daiwa Capital | $105 → $124 | Upgrades | Hold → Outperform |
| 11/08/2019 | 12.6% | CCB International | → $130 | Upgrades | Neutral → Outperform |
| 11/08/2019 | 20.4% | Bernstein | $118 → $139 | Upgrades | Market Perform → Outperform |
| 11/07/2019 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 10/25/2019 | 21.26% | Barclays | $135 → $140 | Maintains | Equal-Weight |
| 10/21/2019 | 29.06% | Keybanc | $152 → $149 | Maintains | Overweight |
| 08/21/2019 | 2.21% | Nomura | $134 → $118 | Maintains | Neutral |
| 08/09/2019 | 28.19% | Keybanc | $160 → $148 | Maintains | Overweight |
| 08/05/2019 | 14.34% | Jefferies | → $132 | Initiates Coverage On | → Buy |
| 07/23/2019 | — | OTR Global | Downgrades | Positive → Mixed | |
| 07/10/2019 | 38.59% | Keybanc | $179 → $160 | Maintains | Overweight |
| 06/28/2019 | 3.94% | JP Morgan | $150 → $120 | Maintains | Neutral |
| 06/04/2019 | 8.27% | Loop Capital | → $125 | Initiates Coverage On | → Hold |
| 05/20/2019 | 27.33% | Nomura | $181 → $147 | Maintains | Neutral |
| 05/20/2019 | 38.59% | Barclays | $200 → $160 | Maintains | Equal-Weight |
| 04/15/2019 | — | China Renaissance | Downgrades | Buy → Hold | |
| 04/10/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 01/22/2019 | 77.57% | Citigroup | $262 → $205 | Maintains | Buy |
| 01/08/2019 | 62.84% | Morgan Stanley | → $188 | Downgrades | Overweight → Equal-Weight |
What is the target price for Baidu (BIDU)?
The latest price target for Baidu (NASDAQ: BIDU) was reported by Nomura Instinet on November 22, 2023. The analyst firm set a price target for $145.00 expecting BIDU to rise to within 12 months (a possible 25.60% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Baidu (BIDU)?
The latest analyst rating for Baidu (NASDAQ: BIDU) was provided by Nomura Instinet, and Baidu upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Baidu (BIDU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Baidu, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Baidu was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Baidu (BIDU) correct?
While ratings are subjective and will change, the latest Baidu (BIDU) rating was a upgraded with a price target of $0.00 to $145.00. The current price Baidu (BIDU) is trading at is $115.45, which is within the analyst's predicted range.